These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16528540)

  • 1. Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia.
    Genné D; Sommer R; Kaiser L; Saaïdia A; Pasche A; Unger PF; Lew D
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):159-66. PubMed ID: 16528540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.
    Arnold FW; Wiemken TL; Peyrani P; Ramirez JA; Brock GN;
    Respir Med; 2013 Jul; 107(7):1101-11. PubMed ID: 23660396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutic aspect of antibiotic therapy during acute community-acquired pneumonia in adults at the University Hospital of Cocody (Abidjan).
    Kouakou-Siransy G; Horo K; Effo E; Kamenan A; N'guessan-Irié G; Boko-Kouassi A; Aka-Anguy E; Die Kakou H
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):940-6. PubMed ID: 26413732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
    Díaz A; Kuzmanic G; Platzer L; Sanfuentes F; Espinoza MA; Saldías F
    Rev Med Chil; 2003 Aug; 131(8):847-56. PubMed ID: 14558238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia].
    Saldías P F; Reyes B T; Sáez B J; Rain M C; Illanes C P; Briceño V C; Díaz P O
    Rev Med Chil; 2015 May; 143(5):553-61. PubMed ID: 26203565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.
    Venditti M; Falcone M; Corrao S; Licata G; Serra P;
    Ann Intern Med; 2009 Jan; 150(1):19-26. PubMed ID: 19124816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
    Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A
    JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.
    Rosón B; Carratalà J; Fernández-Sabé N; Tubau F; Manresa F; Gudiol F
    Arch Intern Med; 2004 Mar; 164(5):502-8. PubMed ID: 15006826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Community acquired pneumonia].
    Marrie TJ
    Praxis (Bern 1994); 2001 May; 90(21):935-40. PubMed ID: 11512537
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization.
    Battleman DS; Callahan M; Thaler HT
    Arch Intern Med; 2002 Mar; 162(6):682-8. PubMed ID: 11911722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
    Aliberti S; Di Pasquale M; Zanaboni AM; Cosentini R; Brambilla AM; Seghezzi S; Tarsia P; Mantero M; Blasi F
    Clin Infect Dis; 2012 Feb; 54(4):470-8. PubMed ID: 22109954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De-escalation therapy among bacteraemic patients with community-acquired pneumonia.
    Carugati M; Franzetti F; Wiemken T; Kelley RR; Peyrani P; Blasi F; Ramirez J; Aliberti S
    Clin Microbiol Infect; 2015 Oct; 21(10):936.e11-8. PubMed ID: 26115864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
    Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
    Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late treatment failure in community-acquired pneumonia.
    Garcia-Vidal C; Carratalà J
    Semin Respir Crit Care Med; 2009 Apr; 30(2):154-60. PubMed ID: 19296415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of severe community-acquired pneumonia among younger patients: an analysis of 18 years at a community hospital.
    Ishida T; Tachibana H; Ito A; Tanaka M; Tokioka F; Furuta K; Nishiyama A; Ikeda S; Niwa T; Yoshioka H; Arita M; Hashimoto T
    J Infect Chemother; 2014 Aug; 20(8):471-6. PubMed ID: 24951291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.